Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06728189
What this trial is testing

A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Peking University Cancer Hospital & Institute 13
Early research (Phase 1)Active Not RecruitingNCT05714748
What this trial is testing

Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors

Who this might be right for
Malignant Tumors
West China Hospital 19
Testing effectiveness (Phase 2)Study completedNCT03220035
What this trial is testing

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 4
Not applicableLooking for participantsNCT07067138
What this trial is testing

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Who this might be right for
Breast CancerBreast CarcinomaCancer of the Breast+1 more
National Cancer Institute (NCI) 175
Early research (Phase 1)Study completedNCT05383703
What this trial is testing

Clinical Study of MNC-168 Enteric-coated Capsule in the Treatment of Advanced Intestinal Solid Tumor

Who this might be right for
Advanced Malignant Solid Tumors
Moon (Guangzhou) Biotechnology Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT00118183
What this trial is testing

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+5 more
National Cancer Institute (NCI) 62
Early research (Phase 1)Active Not RecruitingNCT06571422
What this trial is testing

Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd. 59
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Study completedNCT04908046
What this trial is testing

HMPL-295S1 in Patients With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Hutchmed 47
Testing effectiveness (Phase 2)Looking for participantsNCT06320405
What this trial is testing

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm+1 more
OHSU Knight Cancer Institute 38
Very early researchEnded earlyNCT05271279
What this trial is testing

OVV-01 Injection in Combination With IBR900 Cell Injection in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Solid TumorRelapsed/Refractory Lymphoma
Beijing Boren Hospital 2
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Testing effectiveness (Phase 2)Looking for participantsNCT06650566
What this trial is testing

Study of LM-299 in Subjects Advanced Malignant Tumors

Who this might be right for
Malignant Tumors
LaNova Medicines Limited 108
Large-scale testing (Phase 3)Active Not RecruitingNCT03793166
What this trial is testing

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+6 more
National Cancer Institute (NCI) 1,175
Testing effectiveness (Phase 2)WithdrawnNCT03739606
What this trial is testing

Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center
Early research (Phase 1)UnknownNCT05198752
What this trial is testing

Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Stemirna Therapeutics 30
Early research (Phase 1)Study completedNCT02540876
What this trial is testing

Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant NeoplasmSolid NeoplasmUnresectable Malignant Neoplasm
University of Chicago 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05722288
What this trial is testing

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Who this might be right for
Localized Prostate CarcinomaLocally Advanced Cervical CarcinomaLocally Advanced Rectal Carcinoma+15 more
City of Hope Medical Center 49
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00516438
What this trial is testing

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan

Who this might be right for
Malignant Solid Tumors
AstraZeneca 48
Next Page